[{"Assets_0_Q3_USD":225695000.0,"CommonStockSharesOutstanding_0_Q3_shares":115563000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":37054000.0,"NetIncomeLoss_1_Q3_USD":-56682000.0,"NetIncomeLoss_3_Q3_USD":-82894000.0,"StockholdersEquity_0_Q3_USD":-111295000.0,"Ticker":"IMGN","CIK":"855654","name":"IMMUNOGEN INC","OfficialName":"ImmunoGen Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1148965984.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20171109"}]